Skin toxicity of targeted cancer agents: mechanisms and intervention.
about
Epidermal RAF prevents allergic skin diseasePharmacovigilance in oncology: evaluation of current practice and future perspectives.NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesisPersonalized medicine in hematology - A landmark from bench to bedEvolution of targeted therapies in cancer: opportunities and challenges in the clinic.Dermatologic Adverse Events Associated With Use of Adjuvant Lapatinib in Combination With Paclitaxel and Trastuzumab for HER2-Positive Breast Cancer: A Case Series Analysis.Avasimibe encapsulated in human serum albumin blocks cholesterol esterification for selective cancer treatment.
P2860
Q28829587-B9FC966D-DFF9-4AF4-9812-F9008444C0DEQ35183601-CE3F4D70-5A5A-4D8C-ADB0-3A90D041043FQ36580224-E07F6946-763E-45CB-965F-C05FBAA6AB9AQ38263199-77B1FD4D-ED44-43CD-9F19-C7343A05A67BQ38319572-1F13E197-4606-4DC2-AA8B-303C826F8F5FQ41018872-397081B6-6D0E-421F-863E-D1DCD02E9829Q51010232-D02AD7A4-96E2-4473-9A97-09A9037341B1
P2860
Skin toxicity of targeted cancer agents: mechanisms and intervention.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Skin toxicity of targeted cancer agents: mechanisms and intervention.
@en
type
label
Skin toxicity of targeted cancer agents: mechanisms and intervention.
@en
prefLabel
Skin toxicity of targeted cancer agents: mechanisms and intervention.
@en
P2860
P356
P1433
P1476
Skin toxicity of targeted cancer agents: mechanisms and intervention
@en
P2093
Hiral Fontanilla Patel
Ulrich Rodeck
P2860
P304
P356
10.2217/FON.13.62
P407
P577
2013-08-01T00:00:00Z